share_log

10-K: FY2024 Annual Report

10-K: FY2024 Annual Report

10-K:2024財年年報
美股SEC公告 ·  03/28 21:01

牛牛AI助理已提取核心訊息

Safety Shot Inc. reported FY2024 revenue of $702K, up from $203K in 2023, driven by the launch of its blood alcohol detox beverage in December 2023. However, net loss widened to $49.4M from $15.1M, primarily due to increased operating expenses of $39.6M, including $20.5M in stock-based compensation and $7M in marketing costs.The company strengthened its leadership team with key appointments, including Jarrett Boon as CEO and Jordan Schur as President. Safety Shot completed several strategic initiatives, including the acquisition of GBB Drink Lab's assets and intellectual property for $4.9M, and entered into a definitive agreement to acquire Yerbae Brands Corp through an all-stock transaction valued at 20M shares.As of December 31, 2024, Safety Shot had $349K in cash, down from $3.8M year-over-year, and a working capital deficit of $6.8M. The company faces going concern issues but expects potential warrant exercises and strategic partnerships to provide additional funding. Management continues to focus on expanding distribution channels and developing new product formats while managing legal settlements with various parties.
Safety Shot Inc. reported FY2024 revenue of $702K, up from $203K in 2023, driven by the launch of its blood alcohol detox beverage in December 2023. However, net loss widened to $49.4M from $15.1M, primarily due to increased operating expenses of $39.6M, including $20.5M in stock-based compensation and $7M in marketing costs.The company strengthened its leadership team with key appointments, including Jarrett Boon as CEO and Jordan Schur as President. Safety Shot completed several strategic initiatives, including the acquisition of GBB Drink Lab's assets and intellectual property for $4.9M, and entered into a definitive agreement to acquire Yerbae Brands Corp through an all-stock transaction valued at 20M shares.As of December 31, 2024, Safety Shot had $349K in cash, down from $3.8M year-over-year, and a working capital deficit of $6.8M. The company faces going concern issues but expects potential warrant exercises and strategic partnerships to provide additional funding. Management continues to focus on expanding distribution channels and developing new product formats while managing legal settlements with various parties.
Safety Shot Inc. 報告稱2024財年的營業收入爲70.2萬,較2023年的20.3萬有所增長,這得益於其於2023年12月推出的血液酒精解毒飲料。然而,淨虧損擴大至4940萬,較1510萬有所增加,主要由於營業費用增加至3960萬,包括2050萬的股票薪酬和700萬的市場營銷費用。該公司通過關鍵任命加強了其領導團隊,包括 Jarrett Boon 擔任 CEO,Jordan Schur 擔任總裁。Safety Shot 完成了幾個戰略舉措,包括以490萬收購 GBB Drink Lab 的資產和知識產權,並簽署了一項最終協議,通過全股票交易收購 Yerbae Brands CO...展開全部
Safety Shot Inc. 報告稱2024財年的營業收入爲70.2萬,較2023年的20.3萬有所增長,這得益於其於2023年12月推出的血液酒精解毒飲料。然而,淨虧損擴大至4940萬,較1510萬有所增加,主要由於營業費用增加至3960萬,包括2050萬的股票薪酬和700萬的市場營銷費用。該公司通過關鍵任命加強了其領導團隊,包括 Jarrett Boon 擔任 CEO,Jordan Schur 擔任總裁。Safety Shot 完成了幾個戰略舉措,包括以490萬收購 GBB Drink Lab 的資產和知識產權,並簽署了一項最終協議,通過全股票交易收購 Yerbae Brands CORP,交易價值爲2000萬股。截至2024年12月31日,Safety Shot 擁有34.9萬現金,較去年同期的380萬下降,且存在680萬的營運資金赤字。該公司面臨持續經營問題,但預計潛在的認股權證行使和戰略合作伙伴關係將提供額外資金。管理層繼續專注於擴展分銷渠道和開發新產品形式,同時處理與各方的法律和解。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
評論 評論 · 瀏覽 391

熱點推薦

聲明

本頁的譯文內容由軟件翻譯。富途將竭力但卻不能保證翻譯內容之準確和可靠,亦不會承擔因任何不準確或遺漏而引起的任何損失或損害。